Viewing Study NCT00466232


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT00466232
Status: COMPLETED
Last Update Posted: 2015-12-16
First Post: 2007-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
Sponsor: HealthPartners Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module